Skip to main content
. 2021 Jul 23;19:78–84. doi: 10.1016/j.phro.2021.06.001

Fig. 4.

Fig. 4

Mean dose difference between RSG and CRDG for a target located at various cardiac substructures. The location is specified at the title of each subplot. Red bars show dose difference between RSG and CRDG phase at diastole (0%). Gray bars show dose difference between RSG and CRDG phase at systole (40%). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)